Mahidol Oxford Tropical Medicine Research Unit

Mahidol Oxford Tropical Medicine Research Unit
Name	Mahidol Oxford Tropical Medicine Research Unit
Established	1979
Location	Bangkok, Thailand
Affiliations	Mahidol University, University of Oxford
Research fields	Tropical medicine, infectious diseases, epidemiology

Mahidol Oxford Tropical Medicine Research Unit is a clinical research unit in Bangkok affiliated with Mahidol University and University of Oxford. It conducts clinical trials, epidemiological studies, and operational research on tropical and infectious diseases in Southeast Asia, partnering with international organizations and national ministries. The unit has played roles in studies linked to major outbreaks and global health initiatives involving numerous universities, charities, and intergovernmental agencies.

History

The unit was founded with links to Mahidol University and University of Oxford during expansion of tropical medicine research following regional public health needs in the late 20th century, a period that also saw institutions like Wellcome Trust and Centers for Disease Control and Prevention increase activity in Asia. Early collaborations involved investigators with ties to Oxford Tropical Medicine Research Unit networks, researchers who had worked on projects related to World Health Organization programs, and clinicians experienced from trials in settings such as Chiang Mai and Bangkok. Over subsequent decades it engaged in multicenter trials alongside partners including London School of Hygiene & Tropical Medicine, Harvard University, NIH, and Bill & Melinda Gates Foundation-funded consortia, responding to outbreaks like those associated with SARS and H5N1 influenza and contributing to knowledge relevant to COVID-19 pandemic preparedness.

Research Focus and Programs

The unit’s portfolio emphasizes clinical studies on parasitic and viral infections such as Plasmodium falciparum, Plasmodium vivax, dengue virus, and Leptospira species, and bacterial threats including Salmonella enterica serovars linked to enteric fever. Programs examine antimalarial drug resistance related to mutations characterized by researchers collaborating with groups studying kelch13 markers and partner sites across the Greater Mekong Subregion. Vaccine and immunology projects connect with teams working on dengue vaccine trials and immunogenicity assessments similar to work by PATH and GAVI. Operational research addresses antimicrobial resistance narratives aligned with initiatives by World Health Organization and Wellcome Trust AMR programs, while vector control research relates to projects associated with Bill & Melinda Gates Foundation and regional ministries in settings such as Mekong River provinces. Clinical pharmacology studies integrate methods used by investigators from Imperial College London and University of California, San Francisco.

Facilities and Collaborations

Laboratory infrastructure supports molecular diagnostics, clinical pharmacology, and high-containment procedures comparable to facilities in networks including Wellcome Sanger Institute-linked laboratories. The unit collaborates with academic partners like Oxford University Clinical Research Unit (Vietnam), Institut Pasteur establishments, and tertiary hospitals such as Siriraj Hospital and Ramathibodi Hospital for inpatient trials. International partnerships include research consortia with European & Developing Countries Clinical Trials Partnership and bilateral links with National Institutes of Health (United States), while regional networks incorporate ministries of health in Thailand, Cambodia, Myanmar, and Vietnam. Data-sharing and sequencing collaborations align with efforts by GISAID and sequencing hubs used by groups such as Broad Institute and Wellcome Trust collaborators.

Training and Capacity Building

The unit delivers postgraduate clinical research training in collaboration with Mahidol University degree programs and fellowship schemes modeled on training initiatives like those of Fogarty International Center. Short courses and workshops connect with curricula used by London School of Hygiene & Tropical Medicine and capacity-strengthening programs funded by Wellcome Trust and Bill & Melinda Gates Foundation. It hosts doctoral candidates joint-supervised by faculty with appointments at University of Oxford and links to exchange programs with institutions such as Harvard T.H. Chan School of Public Health and University of Melbourne. Training spans laboratory methods, clinical trial design, biostatistics, and ethics, engaging ethics committees similar to those at National Research Council of Thailand and regional institutional review boards.

Governance and Funding

Governance is shaped by institutional agreements between Mahidol University and University of Oxford, advisory boards drawing members from partner universities and funders like Wellcome Trust, Bill & Melinda Gates Foundation, and national research councils including Thailand Research Fund. Funding streams have included competitive grants from entities such as UK Research and Innovation and programmatic support from philanthropic organizations and governmental agencies, with project-specific contracts from organizations like World Health Organization and European Commission research programs.

Impact and Notable Contributions

The unit has contributed to clinical guidelines and peer-reviewed evidence on antimalarial therapy that influenced regional treatment policies and WHO recommendations, collaborating with networks that include World Health Organization technical advisory groups. Its studies on dengue pathogenesis and vaccine responses added to evidence used by developers and public health programs, and its work on enteric fever informed diagnostics and antimicrobial stewardship frameworks linked to Wellcome Trust AMR initiatives. Researchers affiliated with the unit have published alongside investigators from University of Oxford, London School of Hygiene & Tropical Medicine, and Harvard in high-impact journals and participated in multicenter consortia addressing outbreaks such as H5N1 influenza and COVID-19 pandemic. The unit’s capacity-building output has strengthened research systems in Southeast Asia contributing trained investigators now embedded in institutions across Thailand, Cambodia, Myanmar, and Vietnam.

Category:Medical research institutes Category:Tropical medicine